NSC 408: Cholesterol

Cholesterol Metabolism and Functions

Introduction to Lipids and Sterols

  • From lecture 3.2, four types of lipids and their variations were discussed:

    • Fatty acids: These were covered in a prior lecture.

      • Variations in fatty acids include carbon chain length, saturation/unsaturation, and double bond configuration (cis vs. trans).

    • Triglycerides (TGs)

    • Phospholipids

    • Sterols

  • Key Question: What are the functions of sterols? (Refer to Flexbook: Figure 2.371)

Cholesterol as a Precursor to Hormones and Vitamin D

  • Cholesterol is a fundamental precursor molecule for a variety of critical biological compounds, including steroid hormones and Vitamin D.

  • Steroid Hormone Synthesis Pathway:

    • The conversion of cholesterol into various steroid hormones is a multi-step enzymatic process involving specific cytochrome P450 enzymes and hydroxysteroid dehydrogenases.

    • Initial Steps: Cholesterol is first hydroxylated at the 22R22R-position to form 22R22R-Hydroxycholesterol, followed by further hydroxylation at the 20R20R-position to yield 20R,22R20R,22R-Dihydroxycholesterol. Both steps are catalyzed by CYP11A1CYP11A1. This intermediate is then converted to Pregnenolone by CYP11A1CYP11A1.

    • Progesterone Production: Pregnenolone can be transformed into Progesterone by the enzyme HSD3B1/2HSD3B1/2.

    • Corticosteroid Synthesis (e.g., Cortisol, Aldosterone):

      • Pregnenolone can be converted to 17α17\alpha-Hydroxypregnenolone by CYP17A1CYP17A1. This can then be converted to 17α17\alpha-Hydroxyprogesterone by HSD3B2HSD3B2. 17α17\alpha-Hydroxyprogesterone is a precursor to 11-Deoxycortisol (via CYP21A2CYP21A2) and subsequently Cortisol (via CYP11B1CYP11B1).

      • Progesterone can also lead to 11-Deoxycorticosterone (via CYP21A2CYP21A2), then Corticosterone (via CYP11B1/2CYP11B1/2), and finally Aldosterone (via CYP11B2CYP11B2).

      • Cortisol can be metabolized to Cortisone by HSD11B2HSD11B2 and further reduced to Tetrahydrocortisol by SDR5A2/AKR1D1SDR5A2/AKR1D1.

      • Corticosterone can be reduced to Tetrahydrocorticosterone by SDR5A2/AKR1D1SDR5A2/AKR1D1.

    • Androgen Synthesis (e.g., Testosterone):

      • 17α17\alpha-Hydroxypregnenolone is a precursor to Dehydroepiandrosterone (DHEA) via CYP17A1CYP17A1. DHEA can be sulfated to Dehydroepiandrosterone sulfate by SULT2A1SULT2A1.

      • DHEA is converted to Androstenedione by HSD3B2HSD3B2.

      • Androstenedione is converted to Testosterone by HSD17B3HSD17B3. Testosterone can then be reduced to 5α5\alpha-Dihydrotestosterone by SRD5A2SRD5A2.

    • Estrogen Synthesis (e.g., Estrone, 17β17\beta-Estradiol):

      • Androstenedione can be aromatized to Estrone by CYP19A1CYP19A1.

      • Testosterone can be aromatized to 17β17\beta-Estradiol by CYP19A1CYP19A1.

      • Estrone and 17β17\beta-Estradiol can interconvert through the action of HSD17B2/4HSD17B2/4 and HSD17B1HSD17B1 enzymes.

    • Additional Metabolite: 7α7\alpha-Hydroxydehydroepiandrosterone can be formed from DHEA via CYP7B1CYP7B1.

  • Vitamin D Synthesis Pathway:

    • 77-Dehydrocholesterol, a sterol structurally similar to cholesterol, is converted into Previtamin D33 upon exposure to Ultraviolet light.

    • Previtamin D33 spontaneously isomerizes through a non-enzymatic thermal rearrangement to form Vitamin D33 (Cholecalciferol).

    • Vitamin D33 undergoes further hydroxylation steps in the liver and kidneys to become Calcitriol (1,251,25-Dihydroxycholecalciferol), which is the biologically active form of Vitamin D.

Synthesis of Cholesterol

  • Integration with Macronutrient Metabolism: Acetyl-CoA is a pivotal molecule in metabolism, serving as the starting material for cholesterol synthesis and integrating pathways from carbohydrates, fats, and proteins.

  • **Three Key Steps in Cholesterol Synthesis (Flexbook: Figure 6.351 & 6.352):

    1. Acetyl-CoA (CH3COSCoACH_3COSCoA) is first converted to Acetoacetyl-CoA, which is a molecule with 44 carbons.

    2. Acetoacetyl-CoA then forms 33-hydroxy-33-methylglutaryl-CoA (HMG-CoA).

    3. HMG-CoA is subsequently converted to Mevalonate by the enzyme HMG-CoA reductase. This enzyme is recognized as the rate-limiting enzyme in the entire cholesterol synthesis pathway.

Cholesterol Excretion and Reverse Cholesterol Transport

  • Cholesterol is ultimately eliminated from the body through excretion in feces. This process is a crucial component of reverse cholesterol transport, where excess cholesterol is moved from peripheral tissues back to the liver, converted to bile acids, and then expelled.

  • Targeting Strategies to Lower LDL Cholesterol (Practical Implications):

    • Increase CYP7A1CYP7A1 activity: CYP7A1CYP7A1 (cholesterol 7α7\alpha-hydroxylase) is the rate-limiting enzyme in the classic pathway of bile acid biosynthesis from cholesterol. Enhancing its activity increases the conversion of cholesterol into bile acids, thereby reducing overall cholesterol levels.

    • Decrease ABSTABST enzyme activity: ABSTABST (Apical Sodium-dependent Bile acid Transporter) is responsible for reabsorbing bile acids from the intestinal lumen back into the enterohepatic circulation. Inhibiting ABSTABST reduces bile acid reabsorption, leading to increased fecal excretion of bile acids, which, in turn, stimulates the liver to synthesize more bile acids from cholesterol.

    • Consume Soluble Fiber: Soluble dietary fiber can bind to bile acids within the intestine. This binding prevents the reabsorption of bile acids, promoting their excretion. As with ABSTABST inhibition, this process forces the liver to convert more cholesterol into new bile acids, lowering cholesterol levels.

    • (Reference: Chambers, K. F., Day, P. E., Aboufarrag, H. T., & Kroon, P. A. (2019). Polyphenol Effects on Cholesterol Metabolism via Bile Acid Biosynthesis, CYP7A1: A Review. Nutrients, 11(11), 2588. https://doi.org/10.3390/nu11112588)

Regulation of Cholesterol Synthesis

  • The body maintains tight homeostatic control over cholesterol levels through feedback mechanisms.

  • When Cholesterol Levels in Circulation are Too Low:

    • The body responds by increasing its endogenous synthesis of cholesterol from Acetyl-CoA.

    • Concurrently, there is an increase in the intestinal reuptake of bile acids, conserving existing cholesterol resources.

  • When Cholesterol Levels in Circulation are Too High:

    • The body reduces its own cholesterol synthesis from Acetyl-CoA.

    • It increases the excretion of cholesterol into bile.

    • Intestinal reuptake of bile acids is reduced, promoting their fecal elimination and consequently increasing the demand for cholesterol to synthesize new bile acids.

  • Discussion Point: The question of whether dietary cholesterol significantly impacts circulating cholesterol levels is a topic for consideration and ongoing research.